Printer Friendly

Kikkoman, Tohoku University Confirm That Tomato Extract Helps Heal Atopic Dermatitis.

Tokyo, Japan, Mar 9, 2006 - (JCN) - Kikkoman Corporation, in collaboration with Tohoku University, has discovered that the extract of tomato plays a role in healing atopic dermatitis.

The joint research compared two groups of mice: one that had been given tomato extract and the other, naringenin chalcone (NGC), a kind of polyphenol found in tomato peels. Both groups showed favorable results, and symptoms of atopic dermatitis improved. In particular, the administration of NGC inhibited the rise of serum IgE, an indicator of allergy.

Details of the research will be presented at the Annual Meeting of the Japan Society for Bioscience, Biotechnology, and Agrochemistry 2006, to be held in Kyoto from March 25.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Mar 14, 2006
Previous Article:Kikkoman Finds Soy Sauce Bacteria Effective Against Allergies.
Next Article:Mochida Health Care to Launch New Dandruff Shampoo.

Related Articles
Atopic Dermatitis.
Atopic dermatitis.
AnGes MG Finally Starts Phase I Clinical Trial of NF-kappa B Decoy Oligodeoxynucleotide for Atopic Dermatitis.
Calpis Announces New Findings of Lactobacillus Acidophilus Strain L-92.
Kobayashi Pharmaceutical Confirms That Peppermint-Containing Food Helps Alleviate Atopic Dermatitis.
FANCL Announces Anti-atopic Dermatitis Effect of Kale Juice at Recent Academic Meeting.
FAVORINA Launches New Extract Drink Containing Humic and Fulvic Acids.
Tanabe Seiyaku, Maruho Conclude Licensing Agreement for Phosphodiesterase 4 Inhibitor, External Agent for Skin Disease.
Kaneka Obtains Positive Results in Preclinical Trials of Drug Eluting Stent.
Di-(2-ethylhexyl) phthalate enhances atopic dermatitis-like skin lesions in mice.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters